MedPath

Intelligent and Adaptive Control Applied to Powered Walkers

Not Applicable
Completed
Conditions
Cerebral Palsy
Interventions
Device: SurePace Powered Walker User
Registration Number
NCT05465239
Lead Sponsor
Barron Associates, Inc.
Brief Summary

The research is towards an advanced control and computer learning strategy that will intelligently drive a powered walker for people with walking disabilities. The aim of the control strategy is to provide powered assistance that optimally reduces the metabolic cost of walking. The goal of the proposed intelligent walker is to reduce the workload of walking, keeping this population walking longer, providing critical exercise, continued muscle development and improved quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria

Typically developed subjects:

• No walking disabilities

Subjects with CP:

  • Diagnosed with spastic CP
  • GMFCS level II-III
  • Ages 5-25 inclusive
  • No surgeries in last 6 months
  • Able to ambulate 40ft unaided (excluding walker)
  • Understand and follow commands
Exclusion Criteria

Typically developed subjects:

• Observed intramuscular pathology

Subjects with CP:

  • Mental retardation
  • Severe uncontrolled seizures
  • Leg or foot surgery in last 12 months
  • Surgery or significant injury in last 6 months affecting
  • walking ability
  • Inability to ambulate unassisted (other than walker) 40ft
  • without stopping to rest
  • Inability to understand or follow commands

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SurePace Powered Walker UserSurePace Powered Walker UserBefore any formal experiments are conducted, participants will be given an opportunity to "train" with the new powered walker for a pre-defined period of time to eliminate the confounding effects of being unfamiliar with using the device. (See the description of UVA's facilities and Protection of Human Subjects document for additional discussion of safety measures/protocols and Institutional Review Board procedures.) Experiments will consist of one-hour sessions (with adequate rest periods between trials and time for evaluations) in which participants will be asked to walk at a self-selected (comfortable) walking speed through a pre-defined 8 m x 4 m oval course.
Primary Outcome Measures
NameTimeMethod
Metabolic Cost (Oxygen Consumption)Five minutes

Oxygen consumption data will be collected with a Oxycon Mobile (VIASYS Healthcare Inc.) portable indirect calorimetry system. The outcome measure is the reduction in metabolic cost of using the powered walker compared to an unpowered walker.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Virginia Motion Analysis and Motor Performance Lab

🇺🇸

Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath